- As of June 30, 2008, Dynavax reported cash, cash equivalents, marketable securities and investments held by Symphony Dynamo, Inc. (SDI) totaling $63.1 million. This compares to $88.2 million at December 31, 2007.

Other headlines for [DVAX]

• DVAX 11/3/2008 08:00am
  Dynavax Technologies Reports Q3 -$0.14 v -$0.14e, R $8.9M v $9.4Me
  
• DVAX 10/22/2008 07:20am
  Dynavax Technologies Credit Suisse Cuts DVAX to Neutral from Outperform, price target: $1
  
• DVAX 10/22/2008 06:35am
  Dynavax Technologies Oppenheimer Cuts DVAX to Market Perform from Outperform
  
• DVAX 10/21/2008 05:26pm
  Dynavax Technologies FDA advises Merck and DVAX that the balance of risk versus benefit no longer favors continuing HEPLISAV trial- The FDA has also advised the companies that there may be potential for an acceptable more...
  

Healthcare sector headlines

• GENZ Today 09:22am
  Genzyme Corp European Patent on cross-linked Gel Slurries has been revoked by EPO board of appeal- Announces that the opposition they filed against European Patent EP 0466300 B1 to Genzyme Corporation has been more...
  
• NABI Today 09:15am
  Nabi Biopharmaceuticals Increases patent portfolio with receipt of two patents for components of PentaStaph- European Patent Office issued Patent EP No. 0 925 073 that provides composition-of-matter protection in the EU more...
  
• HOLX Today 09:12am
  Hologic, Inc. Price Target lowered to $22 from $24 at Lazard, maintains buy rating
  
• CORT Today 09:00am
  Corcept Therapeutics Incorpora Names Caroline Loewy as new CFO- Ms. Loewy most recently served as CFO of Poniard Pharmaceuticals, a publicly traded biopharmaceutical company, where she was a key driver of that company's corporate more...
  
• LHCG Today 08:57am
  LHC Group Guides FY09 EPS $1.90-2.00 v $1.93e, R $450M-$470M v $436.2Me